Bristol Myers Squibb (BMS) and Johnson & Johnson have decided to terminate a Phase III trial of their jointly developed ...

The TV ad will run through Nov. 16 across major cable channels, including CNN, Fox News and ESPN, a BMS spokesperson told ...

Bristol Myers Squibb and Johnson & Johnson have stopped a phase 3 anticoagulant trial early for futility, closing off one avenue to market for a molecule tipped to generate multibillion-dollar sales.

Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute, tapping into SCRI ...

BMS Holdings Bhd, a retailer and distributor of tiles, stone surfaces, bathware and kitchenware, has been ascribed a 15 times ...

While it is common to hear that drug developers are in the early stages of integrating artificial intelligence with their drug research, discovery, and development efforts, one Bristol Myers Squibb ...

This week, BMS announced a 15-year virtual power purchase agreement (VPPA) with National Grid Renewables for 145 megawatts (MW) of solar at the Texas-based Blevins Project. Combined with the 15-year ...

More than two years after an initial FDA approval in melanoma, Bristol Myers Squibb is moving its PD-1/LAG-3 combo Opdualag into registrational testing in one of the most important oncology disease ...

The company will deliver advanced BMS and support, while Chaiseri handles installation, training, and sustainment for the new ...

[Editor’s note: The hacker requested that we remove the image for legal reasons, so it’s blurry now. We hope all’s well!] Lithium technology has ushered in a new era of batteries with exceptionally ...

The IPO will comprise a public issue of 364.00 million new shares ("Issue Shares") and an offer for sale of 156.00 million existing shares ("Offer Shares"), collectively representing approximately ...